Candidates must normally possess:
- At least a second class honours degree in Life Science or Pharmacy/Pharmacology from a university in the United Kingdom; or
- A qualification deemed by the Joint Management Committee to be equivalent to the above; and/or
- Professional or industrial experience deemed appropriate by the Joint Management
Months of entry
Stratified Medicine aims to improve therapies for patients such that the drug treatments will be individualised for each patient thus improving his/her likelihood of the best response. This approach has huge potential to enhance therapies and the timely development of new treatments for human disease. It is one of the most important concepts in 21st century clinical science and is a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new medicines.
This taught postgraduate Masters programme harnesses Scotland's strengths in Stratified Medicine, Clinical Trials, Bioinformatics and Pharmacogenomics and draws on the current and future needs of the Life Sciences sector. It has been developed in conjunction with the industrial partners of the Stratified Medicine Scotland Innovation Centre (SMS-IC).
Throughout, this programme will integrate basic and clinical sciences. You will benefit from focused training and will graduate better equipped to design, execute and evaluate modern clinical interventions.
This specially funded programme is open to Scottish/EU citizens. Prestigious Scottish Funding Council Awards are available to high calibre applicants for this programme. The awards cover all tuition costs and all you need to do is apply in order to be considered.
The MSc Stratified Medicine & Pharmacological Innovation is a unique postgraduate degree, offered jointly by the University of Aberdeen, University of Glasgow and University of Strathclyde. Students choose to study on campus at either the University of Aberdeen or University of Glasgow.
Qualification and course duration
Course contact details
- School Administrator